Glioblastoma in older patients: survey of specialists identifies need for clarity on assessment

A lack of standardized assessment, plus under-treatment, is contributing to the poor prognosis seen in older patients with glioblastoma, researchers have suggested.

The specialists from cancer centers in the UK and USA constructed an anonymized online survey for members of the Society for Neuro-Oncology community to complete. The survey asked about assessment in new patients aged 70 years or over with gliobastoma – the most common primary malignant tumor among adults.

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.